Vol. 58 No. 2 (2019): Acta Oncologica

Articles

• Treatment of advanced HR+/HER2− breast cancer with new targeted agents in combination with endocrine therapy: a review of efficacy and tolerability based on available randomized trials on everolimus, ribociclib, palbociclib and abemaciclib

  Tea M. Bøttcher, Søren Cold, Anders B. Jensen

  147-153

  Published: 2019-02-01

  • PDF

• Fear and forget: how anxiety impacts information recall in newly diagnosed cancer patients visiting a fast-track clinic

  Minh Hao Nguyen, Ellen M. A. Smets, Nadine Bol, Madelon B. Bronner, Kristien M. A. J. Tytgat, Eugène F. Loos, Julia C. M. van Weert

  182-188

  Published: 2019-02-01

  • PDF

• Anti-müllerian hormone compared with other ovarian markers after childhood cancer treatment

  Anna Nyström, Helena Mörse, Hanna Nordlöf, Karin Wiebe, Maria Artman, Ingrid Øra, Aleksander Giwercman, Emir Henic, Maria Elfving

  218-224

  Published: 2019-02-01

  • PDF

• Potential benefit of MRI-guided IMRT for flank irradiation in pediatric patients with Wilms’ tumor

  F. Guerreiro, E. Seravalli, G. O. Janssens, M. M. van den Heuvel-Eibrink, J. J. W Lagendijk, B. W. Raaymakers

  243-250

  Published: 2019-02-01

  • PDF

• A welcome from the new Editor-in-Chief

  Mef Nilbert

  133-134

  Published: 2019-02-01

  • PDF

• Multi-drug resistance protein 2 (MRP2) expression, adjuvant tamoxifen therapy, and risk of breast cancer recurrence: a Danish population-based nested case-control study

  Cathrine F. Hjorth, Anja S. Nielsen, Henrik T. Sørensen, Timothy L. Lash, Per Damkier, Stephen Hamilton-Dutoit, Deirdre Cronin-Fenton

  168-174

  Published: 2019-02-01

  • PDF

• The impact of training and professional collaboration on the interobserver variation of lung cancer delineations: a multi-institutional study

  Susan Mercieca, José S. A. Belderbos, Angela van Baardwijk, Stefan Delorme, Marcel van Herk

  200-208

  Published: 2019-02-01

  • PDF

• MRI-based tumor inter-fraction motion statistics for rectal cancer boost radiotherapy

  Jean-Paul J. E. Kleijnen, Bram van Asselen, Robbe Van den Begin, Martijn Intven, Johannes P. M. Burbach, Onne Reerink, Marielle E. P. Philippens, Mark de Ridder, Jan J. W. Lagendijk, Bas W. Raaymakers

  232-236

  Published: 2019-02-01

  • PDF

• Expression of survivin does not appear to influence breast cancer recurrence risk

  Lindsay J. Collin, Deirdre P. Cronin-Fenton, Thomas P. Ahern, Kristina B. Christensen, Per Damkier, Stephen Hamilton-Dutoit, Anders Kjaersgaard, Kristina L. Lauridsen, Rami Yacoub, Peer Christiansen, Henrik Toft Sørensen, Timothy L. Lash

  154-161

  Published: 2019-02-01

  • PDF

• Comorbidity of distress experienced by parents of childhood cancer survivors points to the importance of understanding transdiagnostic cognitive–affective mechanisms

  Janine Vetsch, Brittany C. McGill, Ursula M. Sansom-Daly, Kate Hetherington, Sarah J. Ellis, Kate H. Marshall, Claire E. Wakefield

  189-190

  Published: 2019-02-01

  • PDF

• Shared decision making plus early palliative care-implications for use in clinical decision making

  Gerard Vreugdenhil

  225-226

  Published: 2019-02-01

  • PDF

• Sparing the surgical area with stereotactic body radiotherapy for combined treatment of spinal metastases: a treatment planning study

  A. L. Versteeg, J. Hes, J. M. van der Velden, W. Eppinga, N. Kasperts, H. M. Verkooijen, M. van Vulpen, F. C. Oner, E. Seravalli, J. J. Verlaan

  251-256

  Published: 2019-02-01

  • PDF

• Identifying breast cancer susceptibility genes – a review of the genetic background in familial breast cancer

  Camilla Wendt, Sara Margolin

  135-146

  Published: 2019-02-01

  • PDF

• Cancer-related distress in unselected women with newly diagnosed breast or ovarian cancer undergoing BRCA1/2 testing without pretest genetic counseling

  Hildegunn Høberg-Vetti, Geir Egil Eide, Elen Siglen, Wenche Listøl, Marianne Tveit Haavind, Nicoline Hoogerbrugge, Cathrine Bjorvatn

  175-181

  Published: 2019-02-01

  • PDF

• ‘Why us?’ Causal attributions of childhood cancer survivors, survivors’ parents and community comparisons - a mixed methods analysis

  J. Vetsch, C. E. Wakefield, E. L. Doolan, C. Signorelli, B. M. McGill, L. Moore, P. Techakesari, R. Pieters, A. F. Patenaude, M. McCarthy, R. J. Cohn

  209-217

  Published: 2019-02-01

  • PDF

• Prediction of early mortality following stereotactic body radiotherapy for peripheral early-stage lung cancer

  Sarah Baker, Aman Sharma, Robert Peric, Wilma D. Heemsbergen, Joost Jan Nuyttens

  237-242

  Published: 2019-02-01

  • PDF

• Positive sentinel node in luminal A-like breast cancer patients - implications for adjuvant chemotherapy?

  Axel Stenmark Tullberg, Dan Lundstedt, Roger Olofsson Bagge, Per Karlsson

  162-167

  Published: 2019-02-01

  • PDF

• Caregivers of patients receiving long-term treatment with a tyrosine kinase inhibitor (TKI) for gastrointestinal stromal tumour (GIST): a cross-sectional assessment of their distress and burden*

  S.M.C.H. Langenberg, A.K.L Reyners, A.N.M. Wymenga, G.C.M. Sieling, C.M.M Veldhoven, C.M.L. van Herpen, J.B. Prins, W.T.A. van der Graaf

  191-199

  Published: 2019-02-01

  • PDF

• Hyperthyroidism as a late effect in childhood cancer survivors - an Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study

  Camilla T. Clausen, Henrik Hasle, Anna S. Holmqvist, Laura Madanat-Harjuoja, Laufey Tryggvadottir, Finn Wesenberg, Andrea Bautz, Jeanette F. Winther, Sofie de Fine Licht

  227-231

  Published: 2019-02-01

  • PDF

• Comparison of the automatic segmentation of multiple organs at risk in CT images of lung cancer between deep convolutional neural network-based and atlas-based techniques

  Jinhan Zhu, Jun Zhang, Bo Qiu, Yimei Liu, Xiaowei Liu, Lixin Chen

  257-264

  Published: 2019-02-01

  • PDF